logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10839960 B1

PDFFull Text
Date of Patent:
Nov. 17, 2020

Filed:

Aug. 27, 2018

Ophthalmic drug delivery

Applicant:

Eyenovia, Inc., New York, NY (US);

Inventors:

Bernard L. Ballou, Jr., Raleigh, NC (US);

Mark Packer, Eugene, OR (US);

Russell John Mumper, Chapel Hill, NC (US);

Tsontcho Ianchulev, San Mateo, CA (US);

Assignee:

Eyenovia, Inc., New York, NY (US);

Attorney:

Polsinelli PC

Primary Examiner:

Mark V Stevens

Int. Cl.
CPC ...
G16H 40/63 (2018.01); A61M 15/00 (2006.01); G16H 20/17 (2018.01); A61F 9/00 (2006.01); A61B 5/00 (2006.01); B05B 17/06 (2006.01); B05B 17/00 (2006.01); A61B 5/11 (2006.01); G06F 19/00 (2018.01); G16H 40/67 (2018.01); G16H 20/10 (2018.01); G16H 30/20 (2018.01); A61K 8/06 (2006.01); A61K 9/00 (2006.01); A61M 11/00 (2006.01); G16H 15/00 (2018.01); G16H 10/60 (2018.01); A61M 15/02 (2006.01); A61M 11/04 (2006.01);
U.S. Cl.
CPC ...
G16H 40/63 (2018.01); A61B 5/0059 (2013.01); A61B 5/0079 (2013.01); A61B 5/1103 (2013.01); A61B 5/4839 (2013.01); A61F 9/00 (2013.01); A61F 9/0008 (2013.01); A61K 8/06 (2013.01); A61K 9/0048 (2013.01); A61M 11/00 (2013.01); A61M 15/008 (2014.02); B05B 17/0646 (2013.01); B05B 17/0661 (2013.01); B05B 17/0676 (2013.01); G06F 19/00 (2013.01); G06F 19/3418 (2013.01); G16H 20/10 (2018.01); G16H 20/17 (2018.01); G16H 30/20 (2018.01); G16H 40/67 (2018.01); A61F 9/0026 (2013.01); A61M 11/005 (2013.01); A61M 11/042 (2014.02); A61M 15/0083 (2014.02); A61M 15/025 (2014.02); A61M 2205/0205 (2013.01); A61M 2205/0238 (2013.01); A61M 2205/3306 (2013.01); A61M 2205/3368 (2013.01); A61M 2205/3553 (2013.01); A61M 2205/3584 (2013.01); A61M 2205/3592 (2013.01); A61M 2205/36 (2013.01); A61M 2205/3673 (2013.01); A61M 2205/50 (2013.01); A61M 2205/581 (2013.01); A61M 2205/582 (2013.01); A61M 2205/583 (2013.01); A61M 2205/587 (2013.01); A61M 2205/8206 (2013.01); A61M 2209/086 (2013.01); A61M 2210/0612 (2013.01); G06F 19/3456 (2013.01); G16H 10/60 (2018.01); G16H 15/00 (2018.01);
Abstract

The present invention includes and provides a method of delivering a medicament to an eye of a subject in need thereof a solution, the method comprising: (a) providing droplets containing the medicament with a specified average size and average initial ejecting velocity; and (b) delivering the medicament to the eye, where the droplets deliver a percentage of the ejected mass of the droplets to the eye.

Find Patent Forward Citations

Ballou, Jr., Bernard. (2020). Ophthalmic drug delivery (U.S. Patent No. 10839960). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10839960

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…